These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 34520234)
1. Comprehensive Analysis of Gene Expression Profiles Identifies a Chen Z; Chen M; Xue Z; Zhu X Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234 [No Abstract] [Full Text] [Related]
2. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
4. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma. Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978 [TBL] [Abstract][Full Text] [Related]
5. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma. Yang M; He H; Peng T; Lu Y; Yu J Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients. Zheng Y; Wu R; Wang X; Yin C Front Public Health; 2022; 10():860381. PubMed ID: 35462848 [TBL] [Abstract][Full Text] [Related]
7. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma. Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153 [TBL] [Abstract][Full Text] [Related]
8. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H; Xing F BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131 [TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Diagnostic and Prognostic Values of Li M; Wu F; Zheng Q; Wu Y; Wu Y DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of the prognostic signature of a novel demethylation-related gene associated with the clinical features of colon cancer. Kang K; Huang H; Chen Z Int Immunopharmacol; 2024 Sep; 139():112798. PubMed ID: 39079198 [TBL] [Abstract][Full Text] [Related]
12. Identification prognosis-associated immune genes in colon adenocarcinoma. Miao Y; Wang J; Ma X; Yang Y; Mi D Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821 [TBL] [Abstract][Full Text] [Related]
13. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis. Liang X; Cheng Z; Chen X; Li J Front Genet; 2022; 13():955424. PubMed ID: 36046241 [No Abstract] [Full Text] [Related]
14. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
15. Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer. Cao L; Ba Y; Chen F; Zhang S; Zhang H Aging (Albany NY); 2024 Aug; 16(15):11606-11625. PubMed ID: 39115879 [TBL] [Abstract][Full Text] [Related]
16. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma. Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920 [TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
18. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma. Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K Front Oncol; 2022; 12():904464. PubMed ID: 35912258 [TBL] [Abstract][Full Text] [Related]
19. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
20. Construction of an immune gene expression meta signature to assess the prognostic risk of colorectal cancer patients. Orozco-Castaño C; Mejia-Garcia A; Zambrano Y; Combita AL; Parra-Medina R; Bonilla DA; González A; Odriozola A Adv Genet; 2024; 112():207-254. PubMed ID: 39396837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]